News

Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss ...
Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...
Clinical pharmacoeconomics lead says one million people could benefit from weight loss drugs, but cost would be ‘unaffordable ...
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...
Weight loss drugs can cause side effects including nausea, vomiting, diarrhoea, haemorrhoids and constipation, which can ...
GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...
Donald Trump, at 78, is aggressively pursuing his second term, marked by significant policy changes and a noticeable physical ...
Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits.
Weight loss jabs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro) have surged in popularity, becoming one ...
Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...